228 related articles for article (PubMed ID: 32394296)
1. Complexity of Antiplatelet Therapy in Coronary Artery Disease Patients.
Sabouret P; Savage MP; Fischman D; Costa F
Am J Cardiovasc Drugs; 2021 Jan; 21(1):21-34. PubMed ID: 32394296
[TBL] [Abstract][Full Text] [Related]
2. Duration of Dual Antiplatelet Therapy: A Systematic Review for the 2016 ACC/AHA Guideline Focused Update on Duration of Dual Antiplatelet Therapy in Patients With Coronary Artery Disease: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
; Bittl JA; Baber U; Bradley SM; Wijeysundera DN
Circulation; 2016 Sep; 134(10):e156-78. PubMed ID: 27026019
[TBL] [Abstract][Full Text] [Related]
3. Guanxinning tablet for patients who switch from dual antiplatelet therapy to aspirin alone after percutaneous coronary intervention: study protocol for a cluster randomized controlled trial.
Li J; Ju J; Chen Z; Liu J; Lu F; Gao R; Xu H
Trials; 2018 Feb; 19(1):93. PubMed ID: 29415754
[TBL] [Abstract][Full Text] [Related]
4. [ANMCO/ANCE/ARCA/GICR-IACPR intersociety consensus document: long-term antiplatelet therapy in patients with coronary artery disease].
Gulizia MM; Colivicchi F; Abrignani MG; Ambrosetti M; Aspromonte N; Barile G; Caporale R; Casolo G; Chiuini E; Di Lenarda A; Faggiano P; Gabrielli D; Geraci G; La Manna AG; Maggioni AP; Marchese A; Massari FM; Mureddu GF; Musumeci G; Nardi F; Panno AV; Pedretti RFE; Piredda M; Pusineri E; Riccio C; Rossini R; Scotto Di Uccio F; Urbinati S; Varbella F; Zito GB; De Luca L
G Ital Cardiol (Rome); 2018 May; 19(5):263-331. PubMed ID: 29853716
[TBL] [Abstract][Full Text] [Related]
5. Bleeding versus thrombosis: role of short DAPT in complex lesions.
Calcagno S; Lucisano L; Mancone M; Cavallo E; Pennacchi M; Stio RE; Sardella G
Minerva Cardioangiol; 2015 Dec; 63(6):533-46. PubMed ID: 26334115
[TBL] [Abstract][Full Text] [Related]
6. Toward Brief Dual Antiplatelet Therapy and P2Y12 Inhibitors for Monotherapy After PCI.
Ayoub A; Ayinapudi K; Al-Ogaili A; Panhwar MS; Dakkak W; LeJemtel T
Am J Cardiovasc Drugs; 2021 Mar; 21(2):153-163. PubMed ID: 32780215
[TBL] [Abstract][Full Text] [Related]
7. Optimal duration of dual antiplatelet therapy after PCI: integrating procedural complexity, bleeding risk and the acuteness of clinical presentation.
Chen H; Power D; Giustino G
Expert Rev Cardiovasc Ther; 2018 Oct; 16(10):735-748. PubMed ID: 30221557
[TBL] [Abstract][Full Text] [Related]
8. Strategies to Optimize Dual Antiplatelet Therapy After Coronary Artery Stenting in Acute Coronary Syndrome.
Paravattil B; Elewa H
J Cardiovasc Pharmacol Ther; 2017 Jul; 22(4):347-355. PubMed ID: 28587584
[TBL] [Abstract][Full Text] [Related]
9. A Meta-Analysis Comparing Aspirin Alone Versus Dual Antiplatelet Therapy for the Prevention of Venous Graft Failure Following Coronary Artery Bypass Surgery.
Hesterberg K; Rawal A; Khan S; Rashid A; Jones D; Siddiqui T; Khader TA; Nayyar M; Shah R
Cardiovasc Revasc Med; 2020 Jun; 21(6):792-796. PubMed ID: 31672535
[TBL] [Abstract][Full Text] [Related]
10. Long-term antiplatelet therapy following myocardial infarction: implications of PEGASUS-TIMI 54.
Parker WA; Storey RF
Heart; 2016 May; 102(10):783-9. PubMed ID: 26857211
[TBL] [Abstract][Full Text] [Related]
11. The quest for safer antithrombotic treatment regimens in patients with coronary artery disease: new strategies and paradigm shifts.
Moon JY; Franchi F; Rollini F; Angiolillo DJ
Expert Rev Hematol; 2018 Jan; 11(1):5-12. PubMed ID: 29091481
[TBL] [Abstract][Full Text] [Related]
12. Shorter (≤6 months) versus longer (≥12 months) duration dual antiplatelet therapy after drug eluting stents: a meta-analysis of randomized clinical trials.
Pandit A; Giri S; Hakim FA; Fortuin FD
Catheter Cardiovasc Interv; 2015 Jan; 85(1):34-40. PubMed ID: 24753084
[TBL] [Abstract][Full Text] [Related]
13. Oral antiplatelet therapy for acute coronary syndromes: aspirin, P2Y12 inhibition and thrombin receptor antagonists.
Bailey AL; Campbell CL
Curr Drug Targets; 2011 Nov; 12(12):1805-12. PubMed ID: 21718239
[TBL] [Abstract][Full Text] [Related]
14. Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical Trial.
Hahn JY; Song YB; Oh JH; Chun WJ; Park YH; Jang WJ; Im ES; Jeong JO; Cho BR; Oh SK; Yun KH; Cho DK; Lee JY; Koh YY; Bae JW; Choi JW; Lee WS; Yoon HJ; Lee SU; Cho JH; Choi WG; Rha SW; Lee JM; Park TK; Yang JH; Choi JH; Choi SH; Lee SH; Gwon HC;
JAMA; 2019 Jun; 321(24):2428-2437. PubMed ID: 31237645
[TBL] [Abstract][Full Text] [Related]
15. [Dual antiplatelet therapy for treatment and secondary prevention of coronary artery disease: indications, modalities and duration].
Degrauwe S; Iglesias JF
Rev Med Suisse; 2016 May; 12(520):1022-6, 1028-34. PubMed ID: 27424342
[TBL] [Abstract][Full Text] [Related]
16. Omitting aspirin in PCI patients: Myth or reality?
Alexopoulos D; Mpahara A; Kassimis G
Cardiovasc Drugs Ther; 2019 Dec; 33(6):711-724. PubMed ID: 31811419
[TBL] [Abstract][Full Text] [Related]
17. Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials.
Costa F; van Klaveren D; James S; Heg D; Räber L; Feres F; Pilgrim T; Hong MK; Kim HS; Colombo A; Steg PG; Zanchin T; Palmerini T; Wallentin L; Bhatt DL; Stone GW; Windecker S; Steyerberg EW; Valgimigli M;
Lancet; 2017 Mar; 389(10073):1025-1034. PubMed ID: 28290994
[TBL] [Abstract][Full Text] [Related]
18. Effect of P2Y12 inhibitor monotherapy versus dual antiplatelet therapy on cardiovascular events in patients undergoing percutaneous coronary intervention: systematic review and meta-analysis.
Wu XT; He RR; Liang SZ; Ye GY; Ding SB
Minerva Med; 2020 Apr; 111(2):173-180. PubMed ID: 32338843
[TBL] [Abstract][Full Text] [Related]
19. Meta-Analysis of Duration of Dual Antiplatelet Therapy in Acute Coronary Syndrome Treated With Coronary Stenting.
Knijnik L; Fernandes M; Rivera M; Cardoso R; Goyal A; Liberman H; Sperling LS; McDaniel MC
Am J Cardiol; 2021 Jul; 151():25-29. PubMed ID: 34049672
[TBL] [Abstract][Full Text] [Related]
20. Clinically significant bleeding with low-dose rivaroxaban versus aspirin, in addition to P2Y12 inhibition, in acute coronary syndromes (GEMINI-ACS-1): a double-blind, multicentre, randomised trial.
Ohman EM; Roe MT; Steg PG; James SK; Povsic TJ; White J; Rockhold F; Plotnikov A; Mundl H; Strony J; Sun X; Husted S; Tendera M; Montalescot G; Bahit MC; Ardissino D; Bueno H; Claeys MJ; Nicolau JC; Cornel JH; Goto S; Kiss RG; Güray Ü; Park DW; Bode C; Welsh RC; Gibson CM
Lancet; 2017 May; 389(10081):1799-1808. PubMed ID: 28325638
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
